GlassScriptPhysician profile
Suzanne M Rosenberg
NPI 1275799223
$2,167.91
in general payments reported to CMS, 2019-2025
13 companies · $994 in 2025
The $994 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $15.39 · 2021: $55.04 · 2022: $147 · 2023: $290 · 2024: $362 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $473.30 | 2019-2025 | Tryptyr, Clareon, Precision7 |
| Bausch & Lomb Americas INC. | $468.90 | 2023-2025 | Miebo, Xiidra, Lotemax Sm |
| Johnson & Johnson Vision Care, INC. | $452.84 | 2019-2025 | Acuvue |
| Glaukos Corporation | $140.26 | 2025 | Photrexa Viscous and Photrexa |
| Tarsus Pharmaceuticals, INC. | $138.65 | 2024-2025 | Xdemvy |
| Shire North American Group INC | $137.34 | 2019 | |
| Biotissue Holdings INC. | $100.02 | 2024 | |
| Optovue, INC. | $68.06 | 2019 | |
| Coopervision INC. | $60.08 | 2024 | Misight Contact Lens |
| Oyster Point Pharma, INC. | $56.60 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $29.16 | 2025 | |
| Lombart Brothers, INC. | $21.99 | 2022 | |
| Allergan, INC. | $20.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.